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Abstract
Naloxone administration is an important component of resuscitation attempts by emergency 
medical services (EMS) for opioid drug overdoses. However, EMS providers must first recognize 
the possibility of opioid overdose in clinical encounters. As part of a public health response to an 
outbreak of opioid overdoses in Rhode Island, we examined missed opportunities for naloxone 
administration and factors potentially influencing EMS providers’ decision to administer 
naloxone. We reviewed medical examiner files on all individuals who died of an opioid-related 
drug overdose in Rhode Island from January 1, 2012 through March 31, 2014, underwent 
attempted resuscitation by EMS providers, and had records available to assess for naloxone 
administration. We evaluated whether these individuals received naloxone as part of their 
resuscitation efforts and compared patient and scene characteristics of those who received 
naloxone to those who did not receive naloxone via chi-square, t-test, and logistic regression 
analyses. One hundred and twenty-four individuals who underwent attempted EMS resuscitation 
died due to opioid overdose. Naloxone was administered during EMS resuscitation attempts in 82 
(66.1%) of cases. Females were nearly three-fold as likely not to receive naloxone as males (OR 
2.9; 95% CI 1.2–7.0; p-value 0.02). Additionally, patients without signs of potential drug abuse 
also had a greater than three-fold odds of not receiving nalox-one (OR 3.3; 95% CI 1.2–9.2; p-
value 0.02). Older individuals, particularly those over age 50, were more likely not to receive 
naloxone than victims younger than age 30 (OR 4.8; 95% CI 1.3–17.4; p-value 0.02). Women, 
older individuals, and those patients without clear signs of illicit drug abuse, were less likely to 
receive naloxone in EMS resuscitation attempts. Heightened clinical suspicion for opioid overdose 
is important given the recent increase in overdoses among patients due to prescription opioids.
Keywords
naloxone; opioid; heroin; emergency medical services; resuscitation
Address correspondence to Dr. Steven Allan Sumner, MD, Centers for Disease Control and Prevention, National Center for Injury 
Prevention and Control, 4770 Buford Highway, NE, Mailstop F-63, Atlanta, GA 30341, USA. hvo5@cdc.gov. 
Declaration of Interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the 
paper.
CDC Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the official 
position of the Centers for Disease Control and Prevention.
HHS Public Access
Author manuscript
Prehosp Emerg Care. Author manuscript; available in PMC 2017 March 01.
Published in final edited form as:














From 1980 to 2013 deaths due to drug poisoning in the United States increased more than 
600%, from about 6,100 to 43,982.1,2 Prescription drugs currently account for the largest 
share of drug overdose deaths, with opioid analgesics involved in 74.2% of prescription drug 
deaths.3 Opioid analgesics, including prescribed medications such as oxycodone, 
methadone, and fentanyl, are intended primarily for pain relief under the direction of a 
physician. However, such medications are often diverted from controlled medical use 
through misuse, illicit trade, and sales.4 Indeed, deaths due to opioid analgesics now surpass 
total deaths involving heroin or cocaine.4
The rapid rise in opioid overdose deaths is also associated with a rise in related emergency 
medical service (EMS) encounters.5 Naloxone is an opioid antagonist whose administration 
during resuscitation efforts serves as an important component in EMS response to opioid 
overdoses.6,7 However, appropriate administration of naloxone depends first on recognition 
of the possibility of opioid overdose in an EMS encounter.
To date, research on the use of naloxone in opioid overdoses has largely focused on heroin 
abuse. Furthermore, there remains a paucity of published information on EMS clinical 
decision making in potential opioid overdose cases.8 In one previous study of opioid 
overdose in Rhode Island from 1997 to 2002, EMS run data indicated that such overdoses 
were primarily among males younger than age 50, suggesting illicit opioid use according to 
the authors.9 In this study, records of physical exam findings were not sufficiently available 
to fully assess EMS clinical decision making around naloxone administration.
Given that most opioid overdoses have traditionally been related to heroin, for which 
injection paraphernalia and injection stigmata are clues to the type of drug involved, EMS 
providers may have difficulty identifying prescription opioid overdose cases. Patient and 
scene characteristics can be critical as they may be the only factors which lead providers to 
contemplate naloxone use, particularly if the resuscitation or treatment protocol being 
followed does not explicitly mention consideration of opioid intoxication. Consequently, 
without clear signs of drug abuse, EMS providers may not consider administering naloxone 
and the potential for effective opioid overdose reversal in prescription drug overdose cases 
could be decreased.
Beginning in November 2013, the state of Rhode Island experienced a rapid rise in drug 
overdose deaths.7 In response, we conducted a comprehensive review of all Rhode Island 
drug overdose deaths that occurred between January 1, 2012 and March 31, 2014, to identify 
potential public health responses. This analysis was conducted in April 2014 and reports on 
one component of the investigation. Specifically, the purpose of this study was to identify 
factors related to nalox-one administration in EMS resuscitation efforts among medical 
examiner-reviewed opioid overdose deaths in Rhode Island. A better understanding of 
factors potentially affecting clinical decision making on nalox-one use could potentially help 
to increase the success of some resuscitation attempts.
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Study Design and Participants
This cross-sectional study examined patient and scene characteristics of individuals who 
died from a drug overdose involving any opioid (including illicit substances such as heroin 
and/or opioid analgesics) in Rhode Island from January 1, 2012 through March 31, 2014. All 
study subjects were certified by the Rhode Island Office of the State Medical Examiners 
(OSME) to have a cause of death attributable to a drug overdose involving an opioid 
(multiple causes of death can be specified by a medical examiner), underwent attempted 
resuscitation by EMS providers, and had EMS or Emergency Department records available 
to assess for naloxone administration in the field. Individuals that were 15 years old or 
younger and those whose cases were reviewed in absentia (without autopsy or inspection of 
the body) were excluded from the study.
Rhode Island maintains a single, centralized OSME office through which all drug overdose 
deaths are assessed. Where available, OSME records include a scene narrative prepared by a 
state death investigator, police reports, EMS run sheets, Emergency Department and medical 
records, autopsy reports, and toxicology results. Rhode Island medical examiners can test for 
multiple opioids, including fentanyl, methadone, and oxycodone, as well as other opioids 
and opioid metabolites. Demographic information on each individual was supplemented 
with death certificates from Rhode Island’s Office of Vital Records. Information on patient 
and scene characteristics was abstracted by study investigators.
In this cross sectional study, individuals who received naloxone as part of EMS resuscitation 
efforts were compared to those who did not receive nalox-one as part of EMS resuscitation 
efforts. EMS providers included both fire department and ambulance responders; it was not 
possible to disaggregate the identity of the provider-type.
Statistical Analyses
Among individuals deceased due to opioid overdose, we calculated the proportion who 
received nalox-one during their attempted resuscitation by EMS providers. Additionally, we 
coded patient and scene characteristics potentially observable by EMS and explored to what 
degree such factors predict naloxone administration. Factors examined include age, gender, 
race/ethnicity, body mass index (BMI), location of the overdose, signs of drug abuse, and 
medical examiner determination that the overdose was a suicide attempt. Signs of drug 
abuse were defined as any mention of drug paraphernalia from scene reports (includes 
needles, syringes, crude illicit substances, objects with drug residue, crack pipes, 
tourniquets, drug preparation tools, and others); a needle found directly in the vein of the 
patient by EMS, police, or other investigators; or visualization of fresh track marks noted by 
any official involved. For this item, only signs of illicit drug abuse were considered and thus 
would not include details on prescription medication bottles. Chi-square, Fisher exact, and t-
tests were used to assess statistically significant differences.
Finally, unadjusted and adjusted multivariable logistic regression models were used to 
explore how observable patient and scene characteristics predict naloxone administration. 
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Adjusted models included all terms found to be significant predictors (p < 0.05) of naloxone 
administration at the unadjusted level. All analyses were conducted in SAS (version 9.3).
RESULTS
One hundred twenty-four individuals met our inclusion criteria. Of these individuals, all of 
whom were determined by the medical examiner to have a cause of death attributable to 
opioids, 82 (66.1%) received naloxone as part of EMS resuscitation attempts. Over the 
entire study period, January 1, 2012 through March 31, 2014, the percentage of all overdose 
patients who received naloxone during EMS resuscitation attempts varied by quarter, 
ranging from 57% to 92% (Figure 1). The highest rates of naloxone administration were 
observed from January 1, 2014 through March 31, 2014.
Individuals whose final toxicology results indicated the presence of heroin had received 
naloxone (75%) to a greater degree than individuals dying of non-heroin opiates (57.8%) 
(Table 1). To explore factors that may have influenced EMS providers’ decisions to give 
naloxone in resuscitation attempts, we examined various patient and scene characteristics 
(Table 1). While 86.7% of patients younger than age 30 received naloxone, only 65.4% of 
those age 30 to 50, and 52.4% of those older than age 50 received naloxone (p-value <0.01). 
Females were also significantly less likely to receive naloxone than males (46.9% vs. 74.2%, 
p-value 0.01). Lastly, in situations where visible signs of potential drug abuse such as drug 
paraphernalia or track marks were not present, fewer patients received naloxone (55.6% vs 
86.1%, p-value 0.04). Of the three deaths ultimately determined by the medical examiner to 
be suicides, none received naloxone. Naloxone administration did not differ significantly by 
race/ethnicity, BMI, or location of the overdose (home vs. other residence/hotel vs. 
outdoors/car/other/unknown).
After adjusting for all patient and scene characteristics significant at the unadjusted level, 
multivariable logistic regression analyses found that age, gender, and the presence of signs 
of potential drug abuse were associated with naloxone administration (Table 2). When 
compared to individuals younger than age 30, those patients age 30 to 50 were 
approximately three times as likely not to have received naloxone (OR 3.2; 95% CI 0.9–
11.3; p-value 0.07) and those over age 50 were nearly five times as likely not to have 
received nalox-one (OR 4.8; 95% CI 1.3–17.4; p-value 0.02). Females were approximately 
three-fold as likely not to receive naloxone as males (OR 2.9; 95% CI 1.2–7.0; p-value 
0.02). Finally, patients without signs of potential illicit drug abuse, such as drug 
paraphernalia or track marks, also had a three-fold increased odds of not receiving naloxone 
(OR 3.3; 95% CI 1.2–9.2; p-value 0.02).
Discussion
In this study we identified differences in the use of naloxone during EMS resuscitation 
attempts in Rhode Island by certain patient and scene characteristics. Among those patients 
found by the medical examiner to have died of an opioid overdose, a significant proportion 
did not receive naloxone per documented records. Consequently, our findings suggest there 
may exist missed opportunities for successful resuscitation. Findings demonstrate 
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differences in naloxone administration, favoring its administration in cases where scene 
characteristics suggest illicit drug use.
The proportion of resuscitation attempts in which naloxone was administered was highest in 
the most recent quarter. Indeed, during January through March, 2014, 92% of patients who 
died of an opioid overdose appropriately received naloxone in the attempted resuscitation. 
This may have occurred because of a higher index of suspicion among EMS personnel 
during a concurrent statewide overdose epidemic that was attributed largely to fentanyl 
produced in a clandestine laboratory and sold illegally.10,11 However, in February 2014, 
Rhode Island also issued a revision to permit emergency medical technicians to administer 
an initial dose of intranasal naloxone by standing order.12 It is possible that this provision 
also contributed to the increased naloxone usage noted during the final period of our study.
Patient-level factors that affect whether EMS providers decide to administer naloxone have 
not been fully elucidated. Prior literature on naloxone use by EMS has focused largely on 
naloxone dosing,8,13 efficacy of administration route,14–16 and protocol and policy 
formation.6,17 Thus, we analyzed several patient and scene characteristics available to EMS 
providers to explore characteristics associated with naloxone administration. We found that 
older individuals, females, and those without signs of illicit drug use were at higher 
likelihood of not receiving naloxone during resuscitation attempts. These treatment patterns 
are consistent with the historically higher rates of heroin overdose among younger males 
who injected heroin.18
With the rise in prescription opioid abuse affecting older, female, and more chronically ill 
patients who use opioid analgesics orally, EMS responders must also consider opioid 
overdose among this patient population. Indeed, from 1999 to 2010, deaths from opioid pain 
medications among women increased five-fold, a rate of increase greater than that among 
men.19 Raised suspicion for potential opioid overdose among broader demographic 
categories is important in EMS clinical decision-making. In general, naloxone is a 
medication with an excellent safety profile and infrequent reports of side effects. Some case 
reports have posited a possible rare association with pulmonary edema, seizures, or 
arrhythmias; however, such patients are often critically ill and these conditions may be a 
consequence of the underlying disease or injury process, such as extreme opioid toxicity or 
hypoxia.20 Patients undergoing opioid intoxication reversal can also become combative. 
Nonetheless, in patients undergoing EMS resuscitation where there is suspicion for opioid 
intoxication, empiric naloxone administration may help save patient’s lives.
Some important limitations of this study should be noted. First, analysis of naloxone use 
patterns was dependent on documentation of naloxone use in clinical records, which often 
occurred through hand written notes. In some instances, naloxone may have been used but 
not recorded by providers. Other research on EMS systems has detected a need for 
improvement and standardization of data collection21 and Rhode Island has since adopted an 
improved method to capture naloxone use. Additionally, record of what scene and patient 
characteristics (e.g., evidence of illicit drug use) were present is also dependent on official 
documentation; misclassification could occur in the event of incomplete recording of such 
characteristics. Second, as in many states, naloxone administration by emergency medical 
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technicians traditionally required authorization by medical control. Third, our analysis was 
restricted to those individuals who met all inclusion criteria and who had records available at 
the time of the study. Some degree of selection bias, though unquantifiable, may be present. 
Fourth, it is impossible to determine retrospectively the degree to which naloxone was 
clinically indicated. Although we have included all patients in whom resuscitation was 
attempted, all patients in our sample ultimately died. Providers may have felt that naloxone 
would not benefit the patient if it appeared that an early window for intervention had passed. 
Nonetheless, naloxone may lead to rhythm improvement in cardiac arrest and has been 
recommended with suspicion of opioid overdose.22 Lastly, although we focused our analysis 
on patient and scene characteristics, it remains unclear to what degree providers use these 
clues to guide treatment decision making.
Conclusion
This research suggests that some individuals who die of opioids may not be initially 
recognized by EMS providers as suffering from opioid intoxication. Because of the growing 
diversity of individuals who are victims of opioid overdose, there exists a need for a high 
level of clinical awareness of the possibility of opioid overdose among first responders. 
Education of first responders on the changing demographics of opiate overdose patients may 
help in increasing recognition of those patients who may benefit from nalox-one 
administration. Treatment of opioid overdose with naloxone is highly effective,23 and 
interventions provided by EMS on scene could lead to improved patient outcomes. 
Multifactorial strategies are needed to effectively prevent and respond to opioid overdose 
deaths, including early administration of nalox-one by bystanders,24 improved physician 
prescribing practices,25 and targeted state policies and laws.26 For EMS, improving response 
to opioid overdose may result in additional successful resuscitations.
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Proportion of opioid-related deaths in which naloxone was administered by emergency 
medical services, Rhode Island, January 2012–March 2014 (N = 124).
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